TWI357823B - Solid dosage forms of combination medicine for tre - Google Patents

Solid dosage forms of combination medicine for tre Download PDF

Info

Publication number
TWI357823B
TWI357823B TW98136960A TW98136960A TWI357823B TW I357823 B TWI357823 B TW I357823B TW 98136960 A TW98136960 A TW 98136960A TW 98136960 A TW98136960 A TW 98136960A TW I357823 B TWI357823 B TW I357823B
Authority
TW
Taiwan
Prior art keywords
tre
solid dosage
dosage forms
combination medicine
medicine
Prior art date
Application number
TW98136960A
Other languages
Chinese (zh)
Other versions
TW201023915A (en
Inventor
Yu Fang Hu
Yao Kun Huang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44851804&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI357823(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to TW98136960A priority Critical patent/TWI357823B/en
Publication of TW201023915A publication Critical patent/TW201023915A/en
Application granted granted Critical
Publication of TWI357823B publication Critical patent/TWI357823B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Description

(V)潤滑劑。 中華民國發明專利第1357823號 發明專利更正後無劃線之申請專利範圍替货本(2015年1月5曰) 3雜本 9·根據申請專利範圍第8項之固體劑型,其中在所述 製造方法之(a)步驟中’該活性成份以及組份(i)至(iv)係 以乾式造粒法製成顆粒性粉末,再加入組份(v)置入至適當的 混合容器内均勻混合以形成混合物。 10.根據申請專利範圍第8項之固體劑型,其中在所述 製造方法之(a)步驟中,該活性成份以及組份(i)至(iv)係 以嗔霧造粒法製成顆粒性粉末,再加入組份(v)置入至適當的' 混合谷器内均勻混合以形成混合物。(V) Lubricant. The invention patent of the Republic of China invention patent No. 1357823 is corrected after the application of the scope of the patent without the scribe line (January 5, 2015) 3 Miscellaneous 9. The solid dosage form according to item 8 of the patent application, wherein the manufacture In the step (a) of the method, the active ingredient and the components (i) to (iv) are prepared into a granular powder by a dry granulation method, and then the component (v) is placed in a suitable mixing container and uniformly mixed. To form a mixture. 10. The solid dosage form according to item 8 of the patent application, wherein in the step (a) of the manufacturing method, the active ingredient and the components (i) to (iv) are made into a granular form by haze granulation. The powder, which is then added to the component (v), is placed in a suitable 'mixed barr' and uniformly mixed to form a mixture.

TW98136960A 2003-11-27 2003-11-27 Solid dosage forms of combination medicine for tre TWI357823B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW98136960A TWI357823B (en) 2003-11-27 2003-11-27 Solid dosage forms of combination medicine for tre

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW98136960A TWI357823B (en) 2003-11-27 2003-11-27 Solid dosage forms of combination medicine for tre

Publications (2)

Publication Number Publication Date
TW201023915A TW201023915A (en) 2010-07-01
TWI357823B true TWI357823B (en) 2012-02-11

Family

ID=44851804

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98136960A TWI357823B (en) 2003-11-27 2003-11-27 Solid dosage forms of combination medicine for tre

Country Status (1)

Country Link
TW (1) TWI357823B (en)

Also Published As

Publication number Publication date
TW201023915A (en) 2010-07-01

Similar Documents

Publication Publication Date Title
CA2413698A1 (en) Endoparasiticidal agents for voluntary oral ingestion by animals
MX2007010541A (en) Compositions and methods of making sustained release liquid formulations.
CN1296412A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
ATE470443T1 (en) INDOL-1-YL ACID DERIVATIVES
WO2001027109A3 (en) Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives
HK1115308A1 (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
WO2005041925A3 (en) Compositions and dosage forms for enhanced absorption
MY136524A (en) New solid pharmaceutical formulations comprising telmisartan and preparation thereof
WO2005107721A3 (en) Pharmaceutical dosage form comprising pellets as well as its manufacturing process
WO2004112719A8 (en) Chemical compounds
WO2006125620A3 (en) Cores and microcapsules suitable for parenteral administration as well as process for their manufacture
WO2006070325A3 (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
NZ710384A (en) A novel formulation of indomethacin
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
SI2729130T1 (en) Darunavir combination formulations
DE60211769D1 (en) A process for the preparation of drug granules, the drug granules and pharmaceutical compositions containing them
MX2008001560A (en) Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds.
ATE442852T1 (en) DELAYED-RELEASE MEDICINAL COMPRISING TRIMETAZIDINE AND METHOD FOR THE PRODUCTION
TW201206453A (en) New use of diatomaceous earth in the pharmaceutical industry
DE602005024554D1 (en) PHARMACEUTICAL COMPOSITION WITH AMLODIPIN BESILATE AND LISINOPRILED DIHYDRATE AND METHOD OF MANUFACTURING THEREOF
ATE459342T1 (en) STABILIZED SOLID MEDICINAL FORMS CONTAINING ACTIVE INGREDIENT AND TRIMAGNESIUM DICITRATE AS DESICCANTS AND METHOD FOR THE PRODUCTION THEREOF
TWI357823B (en) Solid dosage forms of combination medicine for tre
JP2009513165A5 (en)
ATE419838T1 (en) PHARMACEUTICAL PREPARATION FORM OF ALIPHATIC AMINE POLYMERS AND METHOD FOR THE PRODUCTION THEREOF
DE50204789D1 (en) NEW 1-AMIDOMETHYL CARBONYL-PIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent